Subject Characteristics and Differences by the Presence or Absence of Comorbid ADHD
Variable . | Total ASD . | ASD (−) ADHD . | ASD (+) ADHD . | P . | Effect Size . |
---|---|---|---|---|---|
(n = 3319) . | (n = 1816; 54.7%) . | (n = 1503; 45.3%) . | |||
Demographic data | |||||
Age, y, mean (SD) | 10.3 (3.08) | 9.9 (3.06) | 10.8 (3.0) | <.001 | 0.30a |
Boys, No. (%) | 2753 (83.0) | 1481 (81.6) | 1272 (84.6) | .019 | 0.04b |
White race, No. (%) | 2894 (87.2) | 1574 (86.7) | 1320 (87.8) | .348 | NA |
Hispanic race and/or ethnicity, No. (%) | 254 (7.7) | 150 (8.3) | 104 (6.9) | .150 | NA |
Phenotypic data | |||||
ID, No. (%) | 649 (19.6) | 381 (21.0) | 268 (17.8) | .023 | 0.04b |
SRS total raw score, mean (SD) | 112.60 (26.10) | 110.04 (26.22) | 115.70 (25.63) | <.001 | 0.22a |
Psychiatric comorbidities, No. (%) | |||||
Anxiety disorder | 1025 (30.9) | 345 (19.0) | 680 (45.2) | <.001 | 0.28b |
Mood disorder | 532 (16.0) | 146 (8.0) | 386 (25.7) | <.001 | 0.24b |
Variable . | Total ASD . | ASD (−) ADHD . | ASD (+) ADHD . | P . | Effect Size . |
---|---|---|---|---|---|
(n = 3319) . | (n = 1816; 54.7%) . | (n = 1503; 45.3%) . | |||
Demographic data | |||||
Age, y, mean (SD) | 10.3 (3.08) | 9.9 (3.06) | 10.8 (3.0) | <.001 | 0.30a |
Boys, No. (%) | 2753 (83.0) | 1481 (81.6) | 1272 (84.6) | .019 | 0.04b |
White race, No. (%) | 2894 (87.2) | 1574 (86.7) | 1320 (87.8) | .348 | NA |
Hispanic race and/or ethnicity, No. (%) | 254 (7.7) | 150 (8.3) | 104 (6.9) | .150 | NA |
Phenotypic data | |||||
ID, No. (%) | 649 (19.6) | 381 (21.0) | 268 (17.8) | .023 | 0.04b |
SRS total raw score, mean (SD) | 112.60 (26.10) | 110.04 (26.22) | 115.70 (25.63) | <.001 | 0.22a |
Psychiatric comorbidities, No. (%) | |||||
Anxiety disorder | 1025 (30.9) | 345 (19.0) | 680 (45.2) | <.001 | 0.28b |
Mood disorder | 532 (16.0) | 146 (8.0) | 386 (25.7) | <.001 | 0.24b |
NA, not applicable.
Cohen’s d.
Phi.